Armata Pharmaceuticals (ARMP) Free Cash Flow Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 66.37% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 3.98% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 137.65% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 23.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.88% |
| Dec 31, 2025 | 14.32% |
| Sep 30, 2025 | 50.67% |
| Jun 30, 2025 | 36.24% |
| Mar 31, 2025 | 29.12% |
| Dec 31, 2024 | 25.28% |
| Sep 30, 2024 | 30.28% |
| Jun 30, 2024 | 6.02% |
| Mar 31, 2024 | 44.67% |
| Dec 31, 2023 | -4.75% |
| Sep 30, 2023 | -13.52% |
| Jun 30, 2023 | -32.29% |
| Mar 31, 2023 | -421.99% |
| Dec 31, 2022 | -13.64% |
| Sep 30, 2022 | -109.65% |
| Jun 30, 2022 | -96.11% |
| Mar 31, 2022 | 35.03% |
| Dec 31, 2021 | -32.36% |
| Sep 30, 2021 | -40.02% |
| Jun 30, 2021 | -14.65% |
| Mar 31, 2021 | -33.14% |
| Dec 31, 2020 | -142.47% |
| Sep 30, 2020 | 12.02% |
| Jun 30, 2020 | 30.64% |
| Mar 31, 2020 | -66.71% |
| Dec 31, 2019 | 23.31% |
| Sep 30, 2019 | -106.99% |
| Jun 30, 2019 | -217.32% |
| Mar 31, 2019 | 26.44% |
| Dec 31, 2018 | -50.23% |
| Sep 30, 2018 | -247.44% |
| Jun 30, 2018 | 36.04% |
| Mar 31, 2018 | -7.02% |
| Dec 31, 2017 | -57.97% |
| Sep 30, 2017 | 80.19% |
| Jun 30, 2017 | 2.78% |
| Mar 31, 2017 | -3.35% |
| Dec 31, 2016 | 36.16% |
| Sep 30, 2016 | -20.93% |
| Jun 30, 2016 | -12.95% |